Free Trial
→ What Steve Bannon revealed about Trump’s gold play (From Reagan Gold Group) (Ad)tc pixel

Vivani Medical's (VANI) Buy Rating Reaffirmed at HC Wainwright

Written by MarketBeat
Updated September 6, 2025
Vivani Medical logo with Medical background

Key Points

  • Vivani Medical's stock rating has been reaffirmed as a "buy" by HC Wainwright, with a price target of $4.00, indicating a potential 247.83% upside from the current price.
  • Vivani Medical's stock opened at $1.15 and reported a recent earnings miss, with EPS of ($0.12) compared to expectations of ($0.10).
  • Institutional investors have increased their stakes in Vivani Medical, with notable purchases including a 796.2% increase by Connective Capital Management, now owning 162,098 shares.
  • Five stocks we like better than Vivani Medical.

Vivani Medical (NASDAQ:VANI - Get Free Report)'s stock had its "buy" rating reissued by equities researchers at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $4.00 price target on the stock. HC Wainwright's target price indicates a potential upside of 210.08% from the company's previous close.

Vivani Medical Stock Down 5.8%

NASDAQ VANI traded down $0.08 on Tuesday, hitting $1.29. The company's stock had a trading volume of 79,673 shares, compared to its average volume of 58,008. Vivani Medical has a 1-year low of $0.91 and a 1-year high of $1.80. The company's 50-day moving average is $1.35 and its 200 day moving average is $1.18. The firm has a market cap of $76.42 million, a PE ratio of -2.87 and a beta of 3.12.

Vivani Medical (NASDAQ:VANI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.02). On average, equities analysts expect that Vivani Medical will post -0.41 EPS for the current year.

Institutional Investors Weigh In On Vivani Medical

Several large investors have recently modified their holdings of the company. Northern Trust Corp increased its position in shares of Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company's stock worth $83,000 after buying an additional 11,540 shares during the period. Panagora Asset Management Inc. acquired a new stake in Vivani Medical in the second quarter worth $25,000. Wealthedge Investment Advisors LLC acquired a new stake in Vivani Medical in the fourth quarter worth $43,000. Jane Street Group LLC acquired a new stake in Vivani Medical in the fourth quarter worth $66,000. Finally, Connective Capital Management LLC grew its holdings in Vivani Medical by 796.2% in the first quarter. Connective Capital Management LLC now owns 162,098 shares of the company's stock worth $170,000 after purchasing an additional 144,010 shares during the period. 6.78% of the stock is currently owned by institutional investors and hedge funds.

About Vivani Medical

(Get Free Report)

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.

Further Reading

Should You Invest $1,000 in Vivani Medical Right Now?

Before you consider Vivani Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.

While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover
7 Stocks to Ride The A.I. Megaboom


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.